Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

Effect of video-based exergaming on arm and cognitive function in persons with multiple sclerosis: A randomized controlled trial.

Ozdogar AT, Ertekin O, Kahraman T, Yigit P, Ozakbas S.

Mult Scler Relat Disord. 2020 Jan 24;40:101966. doi: 10.1016/j.msard.2020.101966. [Epub ahead of print]

PMID:
32045868
2.

Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder.

Kunchok A, Malpas C, Nytrova P, Havrdova EK, Alroughani R, Terzi M, Yamout B, Hor JY, Karabudak R, Boz C, Ozakbas S, Olascoaga J, Simo M, Granella F, Patti F, McCombe P, Csepany T, Singhal B, Bergamaschi R, Fragoso Y, Al-Harbi T, Turkoglu R, Lechner-Scott J, Laureys G, Oreja-Guevara C, Pucci E, Sola P, Ferraro D, Altintas A, Soysal A, Vucic S, Grand'Maison F, Izquierdo G, Eichau S, Lugaresi A, Onofrj M, Trojano M, Marriott M, Butzkueven H, Kister I, Kalincik T.

Mult Scler Relat Disord. 2019 Nov 25;38:101868. doi: 10.1016/j.msard.2019.101868. [Epub ahead of print]

PMID:
31877445
3.

Effect of hormonal changes on the neurological status in the menstrual cycle of patient with multiple sclerosis.

Guven Yorgun Y, Ozakbas S.

Clin Neurol Neurosurg. 2019 Nov;186:105499. doi: 10.1016/j.clineuro.2019.105499. Epub 2019 Sep 10.

PMID:
31541863
4.

Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosis.

Boz C, Terzi M, Özer B, Turkoglu R, Karabudak R, Efendi H, Soysal A, Sevim S, Altintas A, Kurne A, Akçalı A, Akman G, Yüceyar N, Balcı BP, Ekmekci Ö, Karahan SZ, Demirkıran M, Altunrende B, Turan ÖF, Gökçen GözübatıkÇelik, Kale N, Köseoğlu M, Ozakbas S.

Mult Scler Relat Disord. 2019 Nov;36:101376. doi: 10.1016/j.msard.2019.101376. Epub 2019 Aug 26.

PMID:
31473488
5.

Risk of secondary progressive multiple sclerosis: A longitudinal study.

Fambiatos A, Jokubaitis V, Horakova D, Kubala Havrdova E, Trojano M, Prat A, Girard M, Duquette P, Lugaresi A, Izquierdo G, Grand'Maison F, Grammond P, Sola P, Ferraro D, Alroughani R, Terzi M, Hupperts R, Boz C, Lechner-Scott J, Pucci E, Bergamaschi R, Van Pesch V, Ozakbas S, Granella F, Turkoglu R, Iuliano G, Spitaleri D, McCombe P, Solaro C, Slee M, Ampapa R, Soysal A, Petersen T, Sanchez-Menoyo JL, Verheul F, Prevost J, Sidhom Y, Van Wijmeersch B, Vucic S, Cristiano E, Saladino ML, Deri N, Barnett M, Olascoaga J, Moore F, Skibina O, Gray O, Fragoso Y, Yamout B, Shaw C, Singhal B, Shuey N, Hodgkinson S, Altintas A, Al-Harbi T, Csepany T, Taylor B, Hughes J, Jun JK, van der Walt A, Spelman T, Butzkueven H, Kalincik T.

Mult Scler. 2020 Jan;26(1):79-90. doi: 10.1177/1352458519868990. Epub 2019 Aug 9.

PMID:
31397221
6.

The effects of Clinical Pilates training on walking, balance, fall risk, respiratory, and cognitive functions in persons with multiple sclerosis: A randomized controlled trial.

Abasıyanık Z, Ertekin Ö, Kahraman T, Yigit P, Özakbaş S.

Explore (NY). 2019 Jul 17. pii: S1550-8307(19)30053-9. doi: 10.1016/j.explore.2019.07.010. [Epub ahead of print]

PMID:
31377306
7.

Monthly Pulse Methylprednisolone Therapy is Effective in Preventing Permanent Disease Progression in Secondary Progressive Multiple Sclerosis.

Özakbaş S, Çinar BP, Öz D, Kösehasanoğullari G, Kurşun BB, Kahraman T.

Noro Psikiyatr Ars. 2018 Jul 6;56(2):115-118. doi: 10.5152/npa.2017.19339. eCollection 2019 Jun.

8.

Cross-cultural adaptation, validity and reliability of the Turkish version of the patient determined disease steps scale in persons with multiple sclerosis.

Kahraman T, Özdoğar AT, Özakbaş S.

Physiother Theory Pract. 2019 Jun 20:1-8. doi: 10.1080/09593985.2019.1633715. [Epub ahead of print]

PMID:
31218917
9.

The 20-year history: Change of multiple sclerosis patient profile over 20 years.

Ozakbas S, Cinar BP, Kahraman T; Multiple Sclerosis Research Group.

Mult Scler Relat Disord. 2019 Aug;33:1-4. doi: 10.1016/j.msard.2019.05.002. Epub 2019 May 16.

PMID:
31128520
10.

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis.

Kalincik T, Kubala Havrdova E, Horakova D, Izquierdo G, Prat A, Girard M, Duquette P, Grammond P, Onofrj M, Lugaresi A, Ozakbas S, Kappos L, Kuhle J, Terzi M, Lechner-Scott J, Boz C, Grand'Maison F, Prevost J, Sola P, Ferraro D, Granella F, Trojano M, Bergamaschi R, Pucci E, Turkoglu R, McCombe PA, Pesch VV, Van Wijmeersch B, Solaro C, Ramo-Tello C, Slee M, Alroughani R, Yamout B, Shaygannejad V, Spitaleri D, Sánchez-Menoyo JL, Ampapa R, Hodgkinson S, Karabudak R, Butler E, Vucic S, Jokubaitis V, Spelman T, Butzkueven H.

J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):458-468. doi: 10.1136/jnnp-2018-319831. Epub 2019 Jan 13.

PMID:
30636699
11.

Frequency, type, distribution of pain and related factors in persons with multiple sclerosis.

Kahraman T, Özdoğar AT, Ertekin Ö, Özakbaş S.

Mult Scler Relat Disord. 2019 Feb;28:221-225. doi: 10.1016/j.msard.2019.01.002. Epub 2019 Jan 3.

PMID:
30623861
12.

Effects of cigarette smoking on respiratory problems and functional levels in multiple sclerosis patients.

Aktan R, Ozalevli S, Ozakbas S.

Mult Scler Relat Disord. 2018 Oct;25:271-275. doi: 10.1016/j.msard.2018.08.016. Epub 2018 Aug 17.

PMID:
30153625
13.

Prediction of Conversion from Clinically Isolated Syndrome to Multiple Sclerosis According to Baseline Characteristics: A Prospective Study.

Çinar BP, Özakbaş S.

Noro Psikiyatr Ars. 2018 Mar 19;55(1):15-21. doi: 10.29399/npa.12667. eCollection 2018 Mar.

14.

The multiple sclerosis work difficulties questionnaire: translation and cross-cultural adaptation to Turkish and assessment of validity and reliability.

Kahraman T, Özdoğar AT, Honan CA, Ertekin Ö, Özakbaş S.

Disabil Rehabil. 2019 Oct;41(21):2556-2562. doi: 10.1080/09638288.2018.1470262. Epub 2018 May 9.

PMID:
29741962
15.

Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: Multi-center, controlled trial.

Ozakbas S, Turkoglu R, Tamam Y, Terzi M, Taskapilioglu O, Yucesan C, Baser HL, Gencer M, Akil E, Sen S, Turan OF, Sorgun MH, Yigit P, Turkes N.

Mult Scler Relat Disord. 2018 May;22:70-76. doi: 10.1016/j.msard.2018.03.009. Epub 2018 Mar 24.

PMID:
29605801
16.

The Turkish validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery.

Ozakbas S, Yigit P, Cinar BP, Limoncu H, Kahraman T, Kösehasanoğulları G.

BMC Neurol. 2017 Dec 6;17(1):208. doi: 10.1186/s12883-017-0993-0.

17.

Feasibility of a 6-Month Yoga Program to Improve the Physical and Psychosocial Status of Persons with Multiple Sclerosis and their Family Members.

Kahraman T, Ozdogar AT, Yigit P, Hosgel I, Mehdiyev Z, Ertekin O, Ozakbas S.

Explore (NY). 2018 Jan - Feb;14(1):36-43. doi: 10.1016/j.explore.2017.07.006. Epub 2017 Oct 23.

PMID:
29174060
18.

Monthly methylprednisolone in combination with interferon beta or glatiramer acetate for relapsing-remitting multiple sclerosis: A multicentre, single-blind, prospective trial.

Ozakbas S, Cinar BP, Kosehasanoğullari G, Kahraman T, Oz D, Kursun BB.

Clin Neurol Neurosurg. 2017 Sep;160:69-72. doi: 10.1016/j.clineuro.2017.06.016. Epub 2017 Jun 27.

PMID:
28689102
19.

Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: Clinical and MRI results.

Ozakbas S, Cinar BP, Özcelik P, Baser H, Kosehasanoğullari G.

Clin Neurol Neurosurg. 2017 Sep;160:27-29. doi: 10.1016/j.clineuro.2017.05.026. Epub 2017 Jun 1.

PMID:
28622533
20.

Cognitive dysfunction in patients with multiple sclerosis treated with first-line disease-modifying therapy: a multi-center, controlled study using the BICAMS battery.

Cinar BP, Kösehasanoğulları G, Yigit P, Ozakbas S.

Neurol Sci. 2017 Feb;38(2):337-342. doi: 10.1007/s10072-016-2775-7. Epub 2016 Nov 24.

PMID:
27885448

Supplemental Content

Loading ...
Support Center